Design Therapeutics (DSGN)
Develops GeneTAC small molecules that tune disease-causing gene expression.
$12.34
vs last close−0.82 (−6.23%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
−$0.38
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26Apr '26Aug '26Nov '26
Reported−$0.24−$0.31−$0.34−$0.30−$0.27−$0.29−$0.32Pending
Estimate−$0.28−$0.28−$0.32−$0.34−$0.38−$0.36−$0.34−$0.38
Surprise+14.3%−10.7%−6.3%+11.8%+28.9%+19.4%+7.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26Apr '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2030 | $0.24 | — | — |
| Sep 2030 | $0.10 | — | — |
| Jun 2030 | −$0.07 | — | — |
| Mar 2030 | −$0.17 | — | — |
| Dec 2029 | −$0.27 | — | — |
| Sep 2029 | −$0.37 | — | — |
| Jun 2029 | −$0.35 | — | — |
| Mar 2029 | −$0.37 | — | — |
| Dec 2028 | −$0.48 | — | — |
| Sep 2028 | −$0.56 | — | — |
| Jun 2028 | −$0.56 | — | — |
| Mar 2028 | −$0.56 | — | — |
| Dec 2027 | −$0.41 | — | — |
| Sep 2027 | −$0.39 | — | — |
| Jun 2027 | −$0.36 | — | — |
| Mar 2027 | −$0.35 | — | — |
| Dec 2026 | −$0.39 | — | — |
| Nov 2026 | −$0.38 | — | — |
| Aug 2026 | −$0.34 | −$0.32 | +7.1% |
| Apr 2026 | −$0.36 | −$0.29 | +19.4% |
| Mar 2026 | −$0.38 | −$0.27 | +28.9% |
| Nov 2025 | −$0.34 | −$0.30 | +11.8% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Dec 2020 | |||
| Mar 2021 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2030 | $0.24 | — | — | $124.6M | — | — | — |
| Sep 2030 | $0.10 | — | — | $91.8M | — | — | — |
| Jun 2030 | −$0.07 | — | — | $64.3M | — | — | — |
| Mar 2030 | −$0.17 | — | — | $43.4M | — | — | — |
| Dec 2029 | −$0.27 | — | — | $28.3M | — | — | — |
| Sep 2029 | −$0.37 | — | — | $14.7M | — | — | — |
| Jun 2029 | −$0.35 | — | — | $9.1M | — | — | — |
| Mar 2029 | −$0.37 | — | — | $5.6M | — | — | — |
| Dec 2028 | −$0.48 | — | — | $3.4M | — | — | — |
| Sep 2028 | −$0.56 | — | — | $0 | — | — | — |
| Jun 2028 | −$0.56 | — | — | $0 | — | — | — |
| Mar 2028 | −$0.56 | — | — | $0 | — | — | — |
| Dec 2027 | −$0.41 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.39 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.36 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.35 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.39 | — | — | $0 | — | — | — |
| Nov 4, 2026 | −$0.38 | — | — | $0 | — | — | — |
| Aug 3, 2026 | −$0.34 | −$0.32 | +7.1% | — | — | — | +4.8% |
| Apr 28, 2026 | −$0.36 | −$0.29 | +19.4% | — | — | — | 0.0% |
| Mar 9, 2026 | −$0.38 | −$0.27 | +28.9% | — | — | — | +3.2% |
| Nov 5, 2025 | −$0.34 | −$0.30 | +11.8% | — | — | — | +5.0% |
| Aug 7, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 10, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 5, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 19, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 14, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Mar 25, 2021 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |